Remove about responsibility patient-advocacy-engagement-putting-patients-first
article thumbnail

Clinical research in 2021: A new era of collaboration and innovation

pharmaphorum

The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development. Proactive public engagement efforts need to replace age-old recruitment and retention processes”. Yet the most important stakeholder to engage is the patient.

article thumbnail

Rare disease: industry, patients and tech join forces on diagnosis

pharmaphorum

“We’re dealing with very small populations of patients, on top of small populations of specialist physicians who are able to diagnose them,” says Adam Zaeske, formerly head of Rare Diseases, Europe and Canada, at Takeda and now the company’s Head of Portfolio & Pipeline in the region. “On

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

When people think about pharma, they often think about “big” pharma: large, faceless corporations. And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. Caring for a global community. This sets a high bar,” he says. “It

article thumbnail

Patient centricity and the changing pharmaceutical vista

pharmaphorum

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

article thumbnail

More Than Just the Right Words: The Importance of Translations in Clinical Research

ACRP blog

Q: Can you tell us a little bit about how you got into the translations/language services business? Frankly, that just wasn’t the case—the effort put into the original content wasn’t communicated effectively, and the individuals in those target markets lost out as a result. citizens both in the public and private sectors.

article thumbnail

Emotional empathy is driving brand equity

pharmaphorum

Sometimes it is just about style and tone: like a mother’s soothing words to a crying child that create immediate comfort and calm. The emotional wave of the moment is all about reliability, the calm in the storm, the trusted friend. Brands are contributing in myriad different, relevant and engaging ways. How did that happen?

article thumbnail

Chronic Kidney Disease: Diagnostics, Biomarkers and Strategies for More Representative Trials

XTalks

Since CKD is a broad diagnosis that can have a variety of underlying causes, a beneficial focus of current research strategies has been to identify biomarkers and develop diagnostics that can help stratify patients into clinically relevant categories and help guide their management. What is Chronic Kidney Disease?

Trials 52